Company intelligence / Profile preview

Re-Vana Therapeutics

Belfast, Northern Ireland, United Kingdomrevanatx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Re-Vana has demonstrated that its proprietary platforms can achieve six months or greater sustained delivery of anti‑VEGF biologics with high drug loading and controlled burst release. Key nonclinical safety, tolerability, and efficacy studies have been successfully completed. The company’s technology enables office-based administration and aims to reduce the frequency of intravitreal injections required for major retinal diseases.[3][4][5]

Therapeutic areas: Ophthalmology
Modalities: Biologics (e.g., anti-VEGF therapies)Small molecules (e.g., prostaglandins, tyrosine kinase inhibitors)Peptides[1][5][6]Nitric oxide-donating compounds[8]
Industry: Biotech

Drug pipeline

1 asset

EyeLief

Preclinical

Partnerships

Nicox SA – research collaboration on nitric oxide-donor drugs using EyeLief™ platform for glaucoma/intraocular pressure reduction [8]Cambridge Design Partnership – device development partner for OcuLief® formulation [9]Multiple undisclosed global pharmaceutical companies conducting feasibility/preformulation studies [1]

Beyond the preview

Go deeper on Re-Vana Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Re-Vana Therapeutics.

Explore the full profile